Prosecution Insights
Last updated: July 17, 2026
Application No. 18/408,062

FLUORINE REMOVAL FROM ANTIMONY FLUOROHALIDE CATALYST USING CHLOROCARBONS

Non-Final OA §103
Filed
Jan 09, 2024
Priority
Sep 07, 2018 — provisional 62/728,392 +3 more
Examiner
MURESAN, ANA Z
Art Unit
1732
Tech Center
1700 — Chemical & Materials Engineering
Assignee
The Chemours Company FC LLC
OA Round
1 (Non-Final)
75%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 75% — above average
75%
Career Allowance Rate
540 granted / 719 resolved
+10.1% vs TC avg
Strong +31% interview lift
Without
With
+31.3%
Interview Lift
resolved cases with interview
Typical timeline
2y 3m
Avg Prosecution
31 currently pending
Career history
748
Total Applications
across all art units

Statute-Specific Performance

§101
0.4%
-39.6% vs TC avg
§103
59.1%
+19.1% vs TC avg
§102
8.7%
-31.3% vs TC avg
§112
13.7%
-26.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 719 resolved cases

Office Action

§103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . DETAILED ACTION This Office action is responsive to Applicant's Response to Election/Restriction. filed February 20, 2026. As filed, claims 1-14 are pending. Priority This application, filed 01/09/2024 is a Continuation of 17273342 , filed 03/04/2021 ,now U.S. Patent # 11904301 17273342 is a National Stage entry of PCT/US19/49889 , International Filing Date: 09/06/2019 PCT/US19/49889 Claims Priority from Provisional Application 62728392 , filed 09/07/2018. Information Disclosure Statement Applicants' information disclosure statements (IDS) have been considered except where lined through. Please refer to Applicants' copy of the 1449 submitted herewith. Election/Restrictions Applicant's election without traverse of Group II, claims 5-9, drawn to the process to prepare 2,3,3,3-tetrafluoropropene (1234yf) as recited in the claims in the reply filed on 02/20/2026 is acknowledged. Claim 1-4, 10-14 are withdrawn from further consideration pursuant to 37 CFR 1.142(b), as being drawn to a nonelected invention, there being no allowable generic or linking claim. Claims 5-9 will be examined on the merits herein. Claim Interpretation Claim 5 recitation “wherein the chlorine-containing antimony catalyst is prepared by treating a spent antimony fluorohalide catalyst comprising: (i) SbFnXs-n, wherein n is an integer of 1 to 5, and Xis a halogen other than fluorine, (ii) SbFmX'3-m, wherein mis an integer of 1 to 3, and X' is a halogen other than fluorine, or (iii) mixtures of (i) and (ii), with a regenerating agent selected from 2-chloro-3,3,3-trifluoropropene (1233xf), 1, 1, 1,3-tetrachloropropane (250fb ), 2-chloro-l, 1, 1,2-tetrafluoropropane (HCFC- 244bb ), and combinations of two or more of 1233xf, 250fb, and 244bb, under conditions effective to produce the chlorine-containing antimony catalyst from the spent antimony fluorohalide catalyst” is interpreted as product-by-process limitations which are considered to the extent that they limit the structure of the “chlorine-containing antimony catalyst”. Should the Applicant wish to have the limitations treated as actively required process steps then the Applicant should amend the claims so that the step of forming the chlorine-containing antimony catalyst is including in “further comprising” language. See MPEP 2111.04 and MPEP 2113. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102 of this title, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries set forth in Graham v. John Deere Co., 383 U.S. 1, 148 USPQ 459 (1966), that are applied for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 5-9 are rejected under 35 U.S.C. 103 as being unpatentable over US 2010/0331583, Dec. 30, 2010 by Johnson et al. (“the ‘583 publication”; cited by Applicants in IDS) and further in view of GB772484A, 1968, by Oelderik (“the ‘484 publication”; cited by Applicants in IDS). Instant claims are drawn to process to prepare 2,3,3,3-tetrafluoropropene (1234yf) comprising the steps: a) providing a starting composition comprising at least one compound having the structure of Formula I: PNG media_image1.png 200 400 media_image1.png Greyscale wherein each X" is independently selected from F, Cl, Br, and I, provided that at least one of X" is not F; b) contacting said starting composition with HF under conditions effective to produce a first intermediate composition comprising 2-chloro-3,3,3-trifluoropropene (1233xf); c) contacting said first intermediate composition comprising 1233xf with HF and a chlorine-containing antimony catalyst under conditions effective to produce a second intermediate composition comprising 244bb; and d) dehydrochlorinating at least a portion of said 244bb to produce a reaction product comprising 1234yf, wherein the chlorine-containing antimony catalyst is prepared by treating a spent antimony fluorohalide catalyst comprising: (i) SbFnXs-n, wherein n is an integer of 1 to 5, and Xis a halogen other than fluorine, (ii) SbFmX'3-m, wherein mis an integer of 1 to 3, and X' is a halogen other than fluorine, or (iii) mixtures of (i) and (ii), with a regenerating agent selected from 2-chloro-3,3,3-trifluoropropene (1233xf), 1, 1, 1,3-tetrachloropropane (250fb ), 2-chloro-l, 1, 1,2-tetrafluoropropane (HCFC- 244bb ), and combinations of two or more of 1233xf, 250fb, and 244bb, under conditions effective to produce the chlorine-containing antimony catalyst from the spent antimony fluorohalide catalyst. The ‘583 publication teaches a process for producing 2,3,3,3-tetrafluoropropene – which corresponds to the claimed product of the claimed method aka 1234yf- by production of its intermediate 2-chloro-1, 1, 1,2-tetrafluoropropane; wherein the 2-chloro-1, 1, 1,2-tetrafluoropropane is produced by reacting a feed material containing 2-chloro-3,3,3,-trifluoropropene and 2,3-dichloro-3 3-trifluoropropene which corresponds to the claimed Formula I in which X’ is Cl, F with hydrogen fluoride in the presence of a fluorination catalyst and without the need for continuous or intermittent catalyst regeneration. The ‘583 publication teaches that 2-chloro-3,3,3,-trifluoropropene is produced through the fluorination of 1,1,2,3,-tetrachloropropene (HCC-1230xa; instant claim 7) and/or 1,1,1,2,3-tetrachloropropane (HCC-240db), the reaction does not normally proceed completely to forming 2-chloro-3 ,3 ,3, -trifluoropropene. 2,3-dichloro-3 ,3-trifluoropropene is produced as an intermediate – which correspond to steps a and b of claimed method [0008].The production of 2-chloro-1, 1, 1,2-tetrafluoropropane by reacting substantially pure 2-chloro-3 ,3 ,3, -trifluoropropene with hydrogen fluoride and a fluorination catalyst in the absence of an oxidizing agent. The 2-chloro-3,3,3,-trifluoropropene includes a composition of at least 99% 2-chloro-3,3,3-trifluoropropene, it may also include inorganic substrates, e.g. hydrogen fluoride, hydrogen chloride, etc., in any amount, which may be used as a reaction co-feed [0010]- which correspond to steps a and b of claimed method (instant claim 5). Disclosed on [00176] of the cited reference is that process for producing 2,3,3,3-tetrafluoropropene by fluorinating 1,1,2,3,-tetrachloropropene and/or 1,1,1,2,3- tetrachloropropane to produce an intermediate stream comprising 2-chloro-3,3,3-trifluoropropene and one or more impurities. 2-chloro-3,3,3-trifluoropropene is then separated from the intermediate stream to form a substantially pure composition of 2-chloro-3,3,3-trifluoropropene on an organic basis, which is reacted with hydrogen fluoride and a fluorination catalyst in the absence of an oxidizing agent to produce 2-chloro-1,1,1,2-tetrafluoropropane. This product is then dehydrohalogenated under conditions effective to produce 2,3,3,3-tetrafluoropropene; which correspond to step d of claimed method ([0050]-[0055];instant claim 5). The ‘583 publication teaches example 1 on [0057] for production of 2-chloro-3,3,3-trifluoropropene using SbCl5 and SbCl3 as catalyst system which corresponds to the claimed chlorine-containing antimony catalyst (instant claims 7-9). PNG media_image2.png 200 400 media_image2.png Greyscale The method of the present application differs from the method described in the ‘583 publication in that prior art teaches dehydrochlorinating of the 244bb to 1234yf, mediated by SbCl3 and/or SbCl5 chlorine-containing antimony catalyst and it does not teach the catalyst system further comprising an antimony fluorohalide catalyst obtained by treatment with a regenerating agent. However, the ‘583 publication teaches that the catalyst is dried, pre-treated and activated and that it might be advantageous to periodically regenerate the catalyst after prolonged use while in place in the reactor. Pre-treatment can be done by heating the catalyst to about 250° C. to about 430° C. in a stream of nitrogen or other inert gas. The catalyst may then be activated by treating it with a stream of HF diluted with a large excess of nitrogen gas in order to obtain high catalyst activity. Regeneration of the catalyst may be accomplished by any means known in the art [0027]. Therefore, the prior art relied upon, and knowledge generally available in the art before the effective filing date provide the suggestion that would have motivated the skilled artisan to regenerate the catalyst for the transhalogenation reaction. Regarding the limitation of claim 5 “wherein the chlorine-containing antimony catalyst is prepared by …. , under conditions effective to produce the chlorine-containing antimony catalyst from the spent antimony fluorohalide catalyst” is interpreted as product-by-process limitations which are considered to the extent that they limit the structure of the “chlorine-containing antimony catalyst”. Furthermore, it is noted that regeneration of antimony fluorohalide catalyst as alternative and more stable catalyst is known in the prior art as discussed in the ‘484 publication. The ‘484 publication, describes that regenerated hexahalogeno antimonic acid catalysts for transhalogenation reaction by the regeneration of spent hexahalogeno antimonic acid catalysts such as SbF3Cl; such as antimony trifluoride, antimony trifluorodichloride, antimony trifluorodibromide with halopropene enables chlorination of the fluoroantimony halide( page 4-6; see claims). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention, to combine the teachings of the ‘583 publication concerning preparation of producing 2,3,3,3-tetrafluoropropene with the teachings of the ‘484 publication regarding regenerated of antimony fluorohalide as catalyst because the prior art teach specifically teach that catalyst system comprising antimony fluorohalide is stable and efficient for the reaction. The rationale to support a conclusion that the claim would have been obvious is that teaching, suggestion, or motivation in the prior art that would have led one of ordinary skill to modify the prior art reference or to combine prior art reference teachings to arrive at the claimed invention. KSR, 550 U.S. at_, 82 USPQ2d at 1395. Therefore, the claimed invention as a whole is prima facie obvious over the combined teachings of the prior art. Conclusion Claims 5-9 are rejected. Claims 1-4, 19-14 are withdrawn from consideration. Telephone Inquiry Any inquiry concerning this communication or earlier communications from the examiner should be directed to: Ana Muresan (571) 270-7587 (phone) (571)270-8587 (fax) Ana.Muresan@uspto.gov The examiner can normally be reached Monday - Friday (9:00AM - 5:30PM). Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Scarlett Goon can be reached at 571-270-5241. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see https://ppair-my.uspto.gov/pair/PrivatePair. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ANA Z MURESAN/Primary Examiner, Art Unit 1692
Read full office action

Prosecution Timeline

Jan 09, 2024
Application Filed
Jun 16, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12673912
A METHOD FOR THE PREPARATION OF 1,2-PROPANEDIOL, DIPROPYLENE GLYCOL AND TRIPROPYLENE GLYCOL
3y 2m to grant Granted Jul 07, 2026
Patent 12668572
DEGRADABLE LIPID FOR ACTIVE MOLECULE DELIVERY AND LIPID NANOPARTICLE THEREOF
1y 7m to grant Granted Jun 30, 2026
Patent 12662441
ACTIVATION OF ALKYL SUBSTRATES IN CONDENSED PHASE WITH OZONE
3y 2m to grant Granted Jun 23, 2026
Patent 12655097
PROCESSES FOR REMOVING CARBON DISULFIDE FROM SULFIDE PRODUCT STREAMS
1y 2m to grant Granted Jun 16, 2026
Patent 12649830
MULTI-MOTIF DENDRONS AND THEIR SUPRAMOLECULAR STRUCTURES AND USES THEREOF
2y 2m to grant Granted Jun 09, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
75%
Grant Probability
99%
With Interview (+31.3%)
2y 3m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 719 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month